NEW YORK, Sept. 09, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Rockwell Medical, Inc. (NASDAQ: RMTI)
Class Period: November 8, 2017 - June 26, 2018
Lead Plaintiff Deadline: September 25, 2018
Join the action: http://www.zlk.com/pslra-d/rockwell-medical-inc?wire=3
Allegations: Rockwell Medical, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1)
Rockwell was aware that The Centers for Medicare and Medicaid Services will not pursue Rockwell’s proposal for separate
reimbursement for the drug Triferic; (2) the estimated reserves in the first quarter 2018 10-Q are misstated; (3) there was a
material weakness in Rockwell’s internal controls over financial reporting; (4) consequently, Rockwell’s internal controls over
financial reporting were ineffective during the Class Period; (5) Defendant Chioini withheld material information regarding
Triferic from Rockwell’s auditor, corporate counsel and five independent directors of the Board; and (6) as a result, Defendants’
statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked reasonable
bases at all relevant times.
To learn more about the Rockwell Medical, Inc. class action contact jlevi@levikorsinsky.com.
AbbVie Inc. (NYSE: ABBV)
Class Period: May 30, 2018
Lead Plaintiff Deadline: September 24, 2018
Join the action: http://www.zlk.com/pslra-d/abbvie-inc?wire=3
The complaint alleges that AbbVie issued false and misleading statements, in both press releases and filings with the U.S.
Securities and Exchange Commission, regarding the results of the Company's $7.5 billion modified Dutch auction tender offer that
expired on May 29, 2018 (the "Tender Offer"). Specifically, the complaint alleges that before the opening of trading on May 30,
2018, the Company announced that it expected to acquire 71.4 million of its shares tendered at or below $105 per share. As a result
of this news, the price of AbbVie securities significantly increased. However, after the close of trading on May 30, 2018, the
Company released materially different results for the Tender Offer due to certain omissions, announcing that the Company expected
to acquire only those shares tendered at or below $103 per share. Upon this news, AbbVie shares fell from a close of $103.01 per
share on May 30, 2018, to a close of $98.94 on May 31, 2018.
To learn more about the AbbVie Inc. class action contact jlevi@levikorsinsky.com.
Helios and Matheson Analytics Inc. (NASDAQCM: HMNY)
Class Period: August 15, 2017 - July 26, 2018
Lead Plaintiff Deadline: October 1, 2018
Join the action: http://www.zlk.com/pslra-d/helios-and-matheson-analytics-inc?wire=3
Allegations: During the class period, Helios and Matheson Analytics Inc. made materially false and/or misleading statements
and/or failed to disclose that: (i) Helios was touting MoviePass’ valuation and path to profitability; (ii) MoviePass’ business
model was not sustainable, (iii) consequently, Helios would run out of cash, (iv) Defendants’ actions were only reducing
shareholder value, and (v) as a result of the foregoing, Defendants’ statements about Helios’ business, operations, and prospects,
were false and misleading and/or lacked a reasonable basis.
To learn more about the Helios and Matheson Analytics Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
